LAM raises $58M for cancer, rare disease pipeline; What do you pray for?
→ Guilford, CT-based LAM Therapeutics raised a $58 million C round for its work on new drugs for cancer and rare diseases. “This week’s Bert Vogelstein paper in Science showed us that next-generation sequencing and math can help us to understand cancer,” said Jonathan Rothberg, a LAM co-founder and the recipient of the National Medal of Technology for inventing next-generation sequencing. “Sequencing coupled with deep learning is going to enable us to cure cancer.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.